BARCLAYS PLC: SHLS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on SHLS, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 54,296 SHLS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 54,296 sharesChange vs previous 13F -8,679 shares
<0.01% of the 13F portfolio, value $537,532.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 62,975 sharesChange vs previous 13F -611,168 shares
<0.01% of the 13F portfolio, value $414,375.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 674,143 sharesChange vs previous 13F +447,371 shares
<0.01% of the 13F portfolio, value $4,995,401.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 226,772 sharesChange vs previous 13F -74,138 shares
<0.01% of the 13F portfolio, value $752,884.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 300,910 sharesChange vs previous 13F +9,668 shares
<0.01% of the 13F portfolio, value $1,664,033.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 291,242 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,633,867.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).